Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |
Age at menopause
|
phenotype |
|
Finding
|
129
|
209
|
0.100 |
None |
1.000 |
2 |
1
|
2012 |
2019 |
T-lymphocyte deficiency
|
disease |
|
Disease or Syndrome
|
25
|
|
0.020 |
None |
1.000 |
2 |
|
1980 |
1981 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
593
|
24
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cognitive deterioration
|
disease |
|
Mental or Behavioral Dysfunction
|
39
|
3
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Maxillary Sinus Squamous Cell Carcinoma
|
disease |
|
Neoplastic Process
|
24
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
tumor vasculature
|
phenotype |
|
Neoplastic Process
|
200
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
TRICHOMONAS VAGINALIS (finding)
|
disease |
|
Disease or Syndrome
|
56
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Interferon Alpha Measurement
|
phenotype |
|
Laboratory Procedure
|
3
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
PACHYONYCHIA CONGENITA 3
|
disease |
|
Disease or Syndrome
|
209
|
20
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Blood spots
|
disease |
|
Disease or Syndrome
|
117
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Abnormality of B cell physiology
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Impaired T cell function
|
phenotype |
|
Cell or Molecular Dysfunction
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Recurrent lower respiratory tract infection
|
phenotype |
|
Disease or Syndrome
|
23
|
|
0.100 |
None |
|
0 |
|
|
|
Lymph node hypoplasia
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.100 |
None |
|
0 |
|
|
|
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
405
|
39
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Huntington Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
978
|
115
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Combined molybdoflavoprotein enzyme deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Phosphoribosylpyrophosphate Synthetase Superactivity
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
6
|
7
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Purine-nucleoside phosphorylase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
4
|
10
|
0.960 |
None |
1.000 |
17 |
10
|
1979 |
2018 |